A cross-section of UK prostate cancer diagnostics during the coronavirus disease 2019 (COVID-19) era - a shifting paradigm?

Stroman, Luke; Cathcart, Paul; Lamb, Alastair; Challacombe, Ben; Popert, Rick

Stroman, Luke; Cathcart, Paul; Lamb, Alastair; Challacombe, Ben; Popert, Rick.

Stroman L; Guy's Hospital, London, UK.
Cathcart P; Guy's Hospital, London, UK.
Lamb A; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Challacombe B; Guy's Hospital, London, UK.
Popert R; Guy's Hospital, London, UK.

BJU Int ; 127(1): 30-34, 2021 01.

Article in English | MEDLINE | ID: covidwho-998802

Subject(s)

COVID-19/epidemiology; Neoplasm Staging/methods; Prostate/pathology; Prostatic Neoplasms/diagnosis; SARS-CoV-2; Comorbidity; Humans; Incidence; Male; Prostatic Neoplasms/epidemiology; United Kingdom/epidemiology

Keywords

#COVID19; #Coronavirus; #PCSM; #ProstateCancer; #uroonc; Prostate biopsy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Prostate / Prostatic Neoplasms / SARS-CoV-2 / COVID-19 / Neoplasm Staging Type of study: Diagnostic study / Observational study / Randomized controlled trials Limits: Humans / Male Country/Region as subject: Europa Language: English Journal: BJU Int Journal subject: Urology Year: 2021 Document Type: Article Affiliation country: Bju.15259

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google